These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 10551707)

  • 1. Circadian variation of malignant ventricular arrhythmias in patients with ischemic and nonischemic heart disease after cardioverter defibrillator implantation. European 7219 Jewel Investigators.
    Englund A; Behrens S; Wegscheider K; Rowland E
    J Am Coll Cardiol; 1999 Nov; 34(5):1560-8. PubMed ID: 10551707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of a morning peak in ventricular tachycardia and fibrillation events in nonischemic heart disease: analysis of therapies by implantable cardioverter defibrillators.
    Taneda K; Aizawa Y;
    Pacing Clin Electrophysiol; 2001 Nov; 24(11):1602-6. PubMed ID: 11816628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circadian variations of ventricular tachyarrhythmias detected by the implantable cardioverter-defibrillator.
    Auricchio A; Klein H
    G Ital Cardiol; 1997 Feb; 27(2):113-22. PubMed ID: 9199946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circadian patterns in the occurrence of malignant ventricular tachyarrhythmias triggering defibrillator interventions in patients with hypertrophic cardiomyopathy.
    Maron BJ; Semsarian C; Shen WK; Link MS; Epstein AE; Estes NA; Almquist A; Giudici MC; Haas TS; Hodges JS; Spirito P
    Heart Rhythm; 2009 May; 6(5):599-602. PubMed ID: 19332391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).
    Kutyifa V; Moss AJ; Klein H; Biton Y; McNitt S; MacKecknie B; Zareba W; Goldenberg I
    Circulation; 2015 Oct; 132(17):1613-9. PubMed ID: 26316618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circadian, daily, and seasonal distributions of ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillators.
    Anand K; Aryana A; Cloutier D; Hee T; Esterbrooks D; Mooss AN; Mohiuddin SM
    Am J Cardiol; 2007 Oct; 100(7):1134-8. PubMed ID: 17884377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of ventricular tachyarrhythmias occurring in ischemic versus nonischemic patients implanted with a biventricular cardioverter-defibrillator for primary or secondary prevention of sudden death.
    Boriani G; Gasparini M; Lunati M; Santini M; Landolina M; Vincenti A; Curnis A; Bocchiardo M; Padeletti L; Biffi M; Allaria L; Denaro A;
    Am Heart J; 2006 Sep; 152(3):527.e1-11. PubMed ID: 16923425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial Fibrosis Assessment by LGE Is a Powerful Predictor of Ventricular Tachyarrhythmias in Ischemic and Nonischemic LV Dysfunction: A Meta-Analysis.
    Disertori M; Rigoni M; Pace N; Casolo G; Masè M; Gonzini L; Lucci D; Nollo G; Ravelli F
    JACC Cardiovasc Imaging; 2016 Sep; 9(9):1046-1055. PubMed ID: 27450871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circadian variation of sustained ventricular tachyarrhythmias terminated by appropriate shocks in patients with an implantable cardioverter defibrillator.
    Behrens S; Galecka M; Brüggemann T; Ehlers C; Willich SN; Ziss W; Dissmann R; Andresen D
    Am Heart J; 1995 Jul; 130(1):79-84. PubMed ID: 7611127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morning peak in ventricular tachyarrhythmias detected by time of implantable cardioverter/defibrillator therapy. The CPI Investigators.
    Tofler GH; Gebara OC; Mittleman MA; Taylor P; Siegel W; Venditti FJ; Rasmussen CA; Muller JE
    Circulation; 1995 Sep; 92(5):1203-8. PubMed ID: 7648666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circadian variation of sustained ventricular tachycardia in patients with coronary artery disease and implantable cardioverter-defibrillators.
    Lampert R; Rosenfeld L; Batsford W; Lee F; McPherson C
    Circulation; 1994 Jul; 90(1):241-7. PubMed ID: 8026004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian distribution of ischemic attacks and ischemia-related ventricular arrhythmias in patients with variant angina.
    Lanza GA; Patti G; Pasceri V; Manolfi M; Sestito A; Lucente M; Crea F; Maseri A
    Cardiologia; 1999 Oct; 44(10):913-9. PubMed ID: 10630051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of the circadian pattern of ventricular tachyarrhythmias by beta-blocker therapy.
    Behrens S; Ehlers C; Brüggemann T; Ziss W; Dissmann R; Galecka M; Willich SN; Andresen D
    Clin Cardiol; 1997 Mar; 20(3):253-7. PubMed ID: 9068912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversed circadian rhythms of heart rate variability and morning peak occurrence of sustained ventricular tachyarrhythmias in patients with implanted cardioverter defibrillator.
    Fries R; Hein S; K nig J
    Med Sci Monit; 2002 Nov; 8(11):CR751-6. PubMed ID: 12444379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Patients with structural heart disease, syncope of unknown etiology and inducible ventricular arrhythmias treated with implantable defibrillators].
    Aguinaga L; Mont L; Anguera I; Valentino M; Matas M; Brugada J
    Rev Esp Cardiol; 1998 Jul; 51(7):566-71. PubMed ID: 9711105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circadian variations in the occurrence of ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators.
    Kozák M; Krivan L; Semrád B
    Pacing Clin Electrophysiol; 2003 Mar; 26(3):731-5. PubMed ID: 12698674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circadian pattern of spontaneous ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators.
    Eksik A; Akyol A; Norgaz T; Aksu H; Erdinler I; Cakmak N; Alper AT; Cinar B; Yildirim A; Gürkan K
    Med Sci Monit; 2007 Sep; 13(9):CR412-416. PubMed ID: 17767121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High incidence of appropriate implantable cardioverter-defibrillator therapy in patients with syncope of unknown etiology and inducible ventricular arrhythmias.
    Link MS; Costeas XF; Griffith JL; Colburn CD; Estes NA; Wang PJ
    J Am Coll Cardiol; 1997 Feb; 29(2):370-5. PubMed ID: 9014991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Benefit of Cardiac Magnetic Resonance Over Transthoracic Echocardiography for the Assessment of Ischemic and Nonischemic Dilated Cardiomyopathy Patients Referred for the Evaluation of Primary Prevention Implantable Cardioverter-Defibrillator Therapy.
    Pontone G; Guaricci AI; Andreini D; Solbiati A; Guglielmo M; Mushtaq S; Baggiano A; Beltrama V; Fusini L; Rota C; Segurini C; Conte E; Gripari P; Dello Russo A; Moltrasio M; Tundo F; Lombardi F; Muscogiuri G; Lorenzoni V; Tondo C; Agostoni P; Bartorelli AL; Pepi M
    Circ Cardiovasc Imaging; 2016 Oct; 9(10):. PubMed ID: 27729359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diurnal distribution of spontaneous ventricular tachyarrhythmias in patients with implanted cardioverter defibrillator].
    Fries R; Heisel A; Jung J; Stopp M; Schieffer H; Ozbek C
    Z Kardiol; 1996 Feb; 85(2):140-7. PubMed ID: 8650984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.